| 应用AAD方案治疗难治及复发性急性髓系白血病 |
| |
| 引用本文： | 王椿,乔振华,杨林花,张辉,周巧云. 应用AAD方案治疗难治及复发性急性髓系白血病[J]. 白血病．淋巴瘤, 1993, 0(4) |
| |
| 作者姓名： | 王椿 乔振华 杨林花 张辉 周巧云 |
| |
| 作者单位： | 山西医学院第二附属医院，山西医学院第二附属医院，山西医学院第二附属医院，山西医学院第二附属医院，山西省沁县人民医院 030001，030001，030001，030001 |
| |
| 摘 要： | 应用阿克拉霉素,阿糖胞苷和地塞米松(AAD)联合化疗方案对11例难治及复发性急性髓系白血病(AML)患者进行了诱导缓解治疗,总有效率为72.7%,完全缓解率为54.5%,提示AAD方案是治疗难治及复发性AML的有效手段之一,毒副作用小,患者均可耐受。
|
| 关 键 词： | 急性髓系白血病 难治 复发 阿克拉霉素 诱导缓解 |
INDUCTION TREATMENT OF REFRACTORY AND RELAPSING ACUTE MYELOGENOUS LEUKEMIA WITH ACLARUBICIN IN COMBINATION WITH CYTOSINE ARABINOSIDE AND DEXAMETHASONE |
| |
| Wang Chun,et al. INDUCTION TREATMENT OF REFRACTORY AND RELAPSING ACUTE MYELOGENOUS LEUKEMIA WITH ACLARUBICIN IN COMBINATION WITH CYTOSINE ARABINOSIDE AND DEXAMETHASONE[J]. Journal of Leukemia & Lymphoma, 1993, 0(4) |
| |
| Authors: | Wang Chun et al |
| |
| Affiliation: | Wang Chun,et al Department of Hematology,Second Affiliated Hospital of Shanxi Medical College |
| |
| Abstract: | Eleven patients with refractory and relapsing acute myelogenous leukemia (AML) were treated by acombination of aclarubicin, cytosine arabineside and dexamethasone(AAD). Totel efficacious rate was72. 7%, and the rate of complete remission was 54. 5%. The result indicates that AAD regimen wasone of the efficacious approaches to the treatment of refractory and relapsing AML. The side effectswere mild and well tolerated. |
| |
| Keywords: | Acute myelogenous leukemia refractory relapse aclarubicin induction remission |
| 本文献已被 CNKI 等数据库收录！ |
|
